Therapeutic Category
Gastrointestinal
SOVATOP
Pantoprazole-based acid suppression therapy
Gastrointestinal Brand
SOVATOP
SOVATOP contains pantoprazole and is used for the treatment of acid-related gastrointestinal conditions. It is available in both tablet and injectable formulations.
Dosage forms
Tablets and Injection
Strengths Available
40mg
Pack sizes
Pack of 1 vail+10mL Injection, 3x10 Tablets
Therapeutic Indications
- Reflux oesophagitis
- Gastric and duodenal ulcer
- Zollinger – Ellison Syndrome and other pathological hypersecretory conditions.
Brand Name
SOVATOP
Product Name
SOVATOP 40
Generic Name
Pantoprazole Sodium Delayed-Release Tablets 40mg
Dosage Form
Tablets
Pack Size
Pack of 3x10 Tablets
Therapeutic Indication
Indicated for the treatment of GERD, reflux esophagitis, gastric and duodenal ulcers, NSAID-associated ulcers, H. pylori eradication, and hypersecretory conditions such as Zollinger–Ellison syndrome.
Dosage and Method of Administration
Adults: 1 tablet once daily for most indications; twice daily for H. pylori eradication.
For Zollinger–Ellison syndrome, usually 2 tablets daily, adjusted by the physician.
Mode of Administration
For oral use only.
Brand Name
SOVATOP
Product Name
SOVATOP 40
Generic Name
Pantoprazole Injection BP 40mg
Dosage Form
Injection
Pack Size
Combipack of 1 Vial packed with a 10 ml ampoule of Sodium Chloride as the diluent.
Therapeutic Indication
Indicated for the treatment of GERD, reflux esophagitis, gastric and duodenal ulcers, NSAID-associated ulcers, H. pylori eradication, and hypersecretory conditions such as Zollinger–Ellison syndrome.
Dosage and Method of Administration
Adults:
- Gastric & duodenal ulcer, reflux esophagitis: 40mg intravenously once daily.
- Zollinger–Ellison syndrome & pathological hypersecretory conditions: 80mg/day intravenously, administered in two divided doses
Special population:
- Hepatic impairment: Maximum recommended dose is 20mg/day in patients with severe liver impairment.
Mode of Administration
For IV use only.